Labour government

GAOTU TECHEDU INC. (NYSE: GOTU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Gaotu Techedu Inc. f/k/a GSX Techedu Inc.

Retrieved on: 
Monday, January 23, 2023
Investment Technology Group, Policy, K-12, GOTU, GSX, NYSE, The Legal 500, Reuters, Advertising, Financial Times, Court, News, GSX Techedu, Sale, Labour government, District court, Investment, Organization, New Oriental, Tobacco, Tutoring, Security (finance), Great Architect of the Universe

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the American Depositary Shares (“ADSs”) of Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (“Gaotu” or the “Company”) (NYSE: GOTU, GSX) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Eastern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Gaotu purports to be a technology-driven education company, providing online K-12 after-school tutoring services in the People’s Republic of China.
  • If you purchased Gaotu ADSs, and/or would like to discuss your legal rights and options please visit Gaotu Techedu Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

DAKTRONICS, INC. (NASDAQ: DAKT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Daktronics, Inc. (NASDAQ: DAKT)

Retrieved on: 
Monday, January 23, 2023
Tax, The Legal 500, Advertising, Court, News, Labour government, Transport, Disclosure, District court, Investment, Tobacco, Security (finance), Daktronics

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT) between March 10, 2022 and December 6, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Daktronics designs and manufactures electronic scoreboards, programmable display systems, and large screen video displays for sporting, commercial, and transportation applications.
  • Plaintiff alleges that Defendants made materially false and misleading statements, and omitted material facts, throughout the Class Period.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

TWIST BIOSCIENCE CORPORATION (NASDAQ: TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Twist Bioscience Corporation (NASDAQ: TWST)

Retrieved on: 
Monday, January 23, 2023
DNA, Charles Ponzi, Biotechnology, The Legal 500, Advertising, Hospital, Court, Public expenditure, Labour government, Defendant, District court, Scorpion, Investment, Growth, Fraud, News, Tobacco, Renewable energy, Private investigator, Security (finance)

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST) between December 13, 2019 and November 14, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Twist Bioscience Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

F45 TRAINING HOLDINGS INC. (NYSE: FXLV) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against F45 Training Holdings Inc. (NYSE: FXLV)

Retrieved on: 
Monday, January 23, 2023
Registration statement, COVID-19, NYSE, The Legal 500, Advertising, Court, Prospectus, Register, Labour government, IPO, District court, Investment, Growth, Form, Workforce, Exercise, News, Security (finance), Property management, Renewable energy, F45

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired the common stock of F45 Training Holdings Inc. (“F45” or the “Company”) (NYSE: FXLV) pursuant and/or traceable to the Company's false and/or misleading Form S-1 Registration Statement and accompanying Prospectus and Supplemental Prospectus (collectively, the "Registration Statement") issued in connection with the Company's July 16, 2021 initial public offering of 18.75 million shares of common stock, priced at $16 per share (the "July 2021 IPO" or the "Offering"). The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Act of 1933.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Western District of Texas and alleges violations of the Securities Act of 1933.
  • F45 is a fitness franchisor with a business model based on rapid growth through the franchising of low-overhead fitness facilities.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

AFFIRM HOLDINGS, INC. (NASDAQ: AFRM) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Affirm Holdings, Inc. (NASDAQ: AFRM)

Retrieved on: 
Monday, January 23, 2023
CFPB, Consumer, The Legal 500, Consumer Financial Protection Bureau, Advertising, Risk, Court, Sale, Labour government, District court, Investment, News, Security (finance)

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM) between February 12, 2021 and December 15, 2021, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1934.
  • If you purchased or acquired Affirm securities, and/or would like to discuss your legal rights and options please visit Affirm Holdings, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

VERU INC. (NASDAQ: VERU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Veru Inc. (NASDAQ: VERU)

Retrieved on: 
Monday, January 23, 2023
Breast, Steiner, Prostate cancer, Safety, Fast Track, Trial of the century, COVID-19, The Legal 500, Fast track (FDA), Advertising, Court, Health minister, NDA, Labour government, Patient, FDA, District court, EUA, Investment, Mortality, Aerospace, Infection, Death, Prostate Cancer Foundation, News, Tobacco, Security (finance), Pharmaceutical industry, Verus Pharmaceuticals

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) between May 11, 2022 and November 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Veru is primarily an oncology-based biopharmaceutical company that develops drugs for the management of breast and prostate cancers.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

THE GAP, INC. (NYSE: GPS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against The Gap, Inc. (NYSE: GPS)

Retrieved on: 
Monday, January 23, 2023
Gap Inc., GPS, NYSE, The Legal 500, The Wall Street Journal, Advertising, Court, News, Old Navy, Class, Labour government, Gap, District court, Development, Sonia Syngal, Investment, Woman, The Gap, Tobacco, Security (finance), Athleta

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of The Gap, Inc. (“Gap” or the “Company”) (NYSE: GPS) between November 24, 2021 and July 11, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Eastern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Eastern District of New York and alleges violations of the Securities Exchange Act of 1934.
  • The Company offers apparel, accessories, and personal care products for men, women, and children under the Old Navy, Gap, Banana Republic, and Athleta brands.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

GENERAC HOLDINGS INC. (NYSE: GNRC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Generac Holdings Inc. (NYSE: GNRC)

Retrieved on: 
Monday, January 23, 2023
Shock, NYSE, The Legal 500, Advertising, Court, Learning, Labour government, Defendant, District court, Bankruptcy, Investment, News, Security (finance), Renewable energy, Insurance, Generac Holdings

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Generac Holdings Inc. (“Generac” or the “Company”) (NYSE: GNRC) between April 29, 2021 and November 1, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Eastern District of Wisconsin and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Generac is a diversified energy solutions company providing an array of energy management technology as well as prime and backup power solutions.
  • Specifically, Plaintiff alleges that repeated misrepresentations by Generac and its senior executives concealed from investors a defective component at the core of Generac’s solar power products.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NeoGenomics, Inc. (NASDAQ: NEO)

Retrieved on: 
Monday, January 23, 2023
Office of Inspector General, U.S. Department of Health and Human Services, Complaint, The Legal 500, Advertising, Cancer, Hospital, Court, NEO, NGS, Marie Cassidy, EBITDA, Labour government, District court, Human services, Investment, Fraud, News, Tobacco, Pharmaceutical industry, Security (finance), NeoGenomics

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)

Retrieved on: 
Friday, January 20, 2023
RTF, News, Therapy, Advisory Committee, Aerospace, CNS, District court, FDA, Food and Drug Administration, Marketing, Food, Survival, LLP, Patient, Labour government, Court, Cancer, Bias, Letter, Advertising, Investment, The Legal 500, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934.
  • Y-mAbs is a clinical-stage biopharmaceutical company focused on developing antibody therapeutics and medicines for the treatment of cancer patients of all ages.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.